stub Full Spectrum THCA: A Promising Agent in the Fight Against Antibiotic Resistance - MyCannabis.com
Connect with us

Health

Full Spectrum THCA: A Promising Agent in the Fight Against Antibiotic Resistance

mm
Updated on

Antibiotic resistance in staphylococcal strains presents a formidable challenge to global public health and agriculture. The urgent need for novel anti-staphylococcal agents to combat this rising incidence of bacterial resistance is undeniable.

“Complete plant extracts, preferably THCa dominant while retaining the cannabinoid acids, terpenes and flavonoids, are unprecedentedly antibacterial and even kill the MRSA bacteria (hospital bacteria), says Peter Vermuel, founder and CEO of CBD Spain.”

This article highlights a groundbreaking study that explores the potential of ethanolic extracts derived from Cannabis sativa L. in combating Staphylococcus aureus, encompassing both antibiotic-resistant and antibiotic-sensitive strains.

In this study, conducted across various nutritional treatments during the entire vegetation cycle, researchers evaluated the in vitro anti-staphylococcal effects of cannabis extracts. The results unveiled a promising discovery: all tested cannabis extracts exhibited notable growth inhibition against Staphylococcus aureus strains. Particularly intriguing was the observation of peak antibacterial activity during the 5th to the 13th week of plant growth, with minimum inhibitory concentrations ranging from 32 to 64 µg/mL across all nutritional treatments.

Further analysis through High-Performance Liquid Chromatography (HPLC) identified Δ9-tetrahydrocannabinolic acid (THCA) as the predominant cannabinoid in the ethanolic extracts. Additionally, a derivative of THCA, tetrahydrocannabivarinic acid (THCVA), demonstrated a significant reduction in bacterial growth by 74%.

These compelling findings shed light on the potential of cannabis extracts as a source for the development of novel anti-staphylococcal compounds. By harnessing the antibacterial properties of cannabinoids, there is a promising opportunity to address the pressing need for effective strategies against antibiotic resistance. This study serves as a cornerstone for future research endeavors aimed at unlocking the full therapeutic potential of cannabis in combating bacterial infections and safeguarding public health and agricultural systems worldwide.

The study can be accessed here.

 

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.